Date: 25th & 26th April 2018
Location: World Courier Heathrow (Feltham, United Kingdom)
Savsu's Bruce McCormick will be presenting at this workshop which is part of World Courier's Knowledge Series. Other workshop participants are from World Courier, Trakcel, and Catapault (see below for more detail on presenters). You can register here
"2017 was a tipping point for the advanced therapy industry. Reaching commercialization more rapidly, the industry is now presented with new challenges to its logistics infrastructure. Creating commercially viable supply chains is essential but requires the definition of a logistics platform that enables therapies to efficiently move through it as required, in the early stages of the process.
This workshop intends to provide an environment for industry professionals to meet and exchange with other subject matter experts, facing similar challenges in their own supply chain. The interactive format will consider aspects related to current and future business models for each industry as well as the challenges moving from clinical to commercial stage. This session will include workshops with industry leaders providing additional input and insights into how to integrate operations and build a logistics platform."
Jacqueline Barry is Chief Clinical Officer at Cell and Gene Therapy Catapult. Prior to this she worked at the Scottish National Blood Transfusion Service in a number of senior regulatory and quality positions, the responsibility for which included designing the regulatory strategy for the Cellular Therapies developed by the Blood Transfusion Service, acting as Responsible Person for Blood and Qualified Person for medicinal product release. Before that she held a number of post-Doctoral academic posts at the University of Edinburgh studying neuromuscular regeneration. She has considerable experience in the development, translation, clinical trial and approval of cell based medicinal products and therapies.
Simon Ellison is the Cell & Gene Therapy Service Director at World Courier. His role is to develop a portfolio of global logistic and supporting service strategies that take the advanced therapy industry forwards. Whilst at the Cell and Gene Therapy Catapult he identified the need for, and built the Seamless Freight portfolio. He also helped develop the commercial operating model for the Catapult Manufacturing Centre that resulted in the first collaborators entering, and the start of a cluster forming around this unique facility. Prior to this Simon was the Head of Commercial at NHS Blood and Transplant (NHSBT).
Bruce McCormick is the Founder and President of SAVSU Technologies. Inventor and researcher, he has been the recipient of a number of US and foreign patents. His commercial products have included an FDA approved medical device for Cardio/Pulmonary indications as well as insulated insoles which were featured in the USPTO museum exhibit on footwear technology. His other work includes sports medicine inventions relating to measuring hidden motion as well as a Garment Fitting System. Bruce has given presentations at many conferences including the IEEE Engineering in Medicine and Biology Society International Conference and the International Conference on Hypertension.
Matthew Lakelin is VP of Scientific Affairs and Business Development at TrakCel. Using his knowledge in handling and distribution of ATMPs he has assisted with the development of TrakCel’s technology platform. Matthew provides a technical bridge between the software development side of the technology platform and the GxP application of the system. He is also a member of the company’s Quality Unit to ensure that development and configuration of TrakCel’s technology platform adheres to a GAMP-5 framework. Prior to TrakCel, Matthew worked as Head of Technical Support for a specialist clinical supplier company.